Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The new method makes finasteride cheaper and easier to produce.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Researchers made two new compounds that could be used for medicine.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Sebocytes play a key role in controlling androgen levels in human skin.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

A new method accurately measures DHEAS in blood, improving on current tests.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Certain drugs that block specific enzymes can help treat prostate diseases.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.